Aïda Falgàs

Has grant

Hospital de la Santa Creu i Sant Pau

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Grants for the recruitment of early-stage research staff

Open Date: 2017-04-01

Close Date: 2020-04-01

Grant: Close

Grants for the introduction to research

Open Date: 2015-11-01

Close Date: 2016-05-01

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Antonio Villaverde

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Gordon Morris

University of Huddersfield

UNITED KINGDOM

View details

Ramon Mangues

Research Professor (Investigador Titular)

Hospital de la Santa Creu i Sant Pau

SPAIN

View details

Ugutz Unzueta

Associated Professor

University of Barcelona

SPAIN

View details

ramon eritja

Full Professor

Spanish National Research Council (CSIC)

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Aïda Falgàs

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo

A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model

A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4<sup>+</sup> lymphoma cells without toxicity in immunocompromised and immunocompetent mice.

Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery

Time-Prolonged Release of Tumor-Targeted Protein-MMAE Nanoconjugates from Implantable Hybrid Materials.

Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4

Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4+ Cancers

Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4+ Diffuse Large B-Cell Lymphoma Cells

An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination

Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles

Collaborators (5)

Antonio Villaverde

Gordon Morris

Ramon Mangues

Ugutz Unzueta

ramon eritja

Make your next move.